Biocryst Pharmaceuticals Stock Technical Analysis
| BCRX Stock | USD 4.38 0.03 0.68% |
As of the 24th of April, BioCryst Pharmaceuticals shows the Mean Deviation of 2.57, risk adjusted performance of (0.05), and Standard Deviation of 3.51. BioCryst Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for BioCryst Pharmaceuticals, which can be compared to its peers. Please confirm BioCryst Pharmaceuticals variance and skewness to decide if BioCryst Pharmaceuticals is priced correctly, providing market reflects its regular price of 4.38 per share. Given that BioCryst Pharmaceuticals has information ratio of (0.12), we suggest you to validate BioCryst Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
BioCryst Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioCryst, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioCrystBioCryst |
BioCryst Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 15.2 | Strong Buy | 11 | Odds |
Most BioCryst analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioCryst stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioCryst Pharmaceuticals, talking to its executives and customers, or listening to BioCryst conference calls.
BioCryst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioCryst Pharmaceuticals Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioCryst Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BioCryst Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for BioCryst Pharmaceuticals. You can use it to identify possible trend reversals for BioCryst Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioCryst Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BioCryst Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioCryst Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that BioCryst Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 15.16, which is the sum of squared deviations for the predicted BioCryst Pharmaceuticals price change compared to its average price change.About BioCryst Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioCryst Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioCryst Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioCryst Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding BioCryst Pharmaceuticals. By analyzing BioCryst Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioCryst Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioCryst Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 (projected) | Graham Number | 12.48 | 15.3 | 7.93 | Receivables Turnover | 5.34 | 5.35 | 5.82 |
BioCryst Pharmaceuticals April 24, 2024 Technical Indicators
Most technical analysis of BioCryst help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioCryst from various momentum indicators to cycle indicators. When you analyze BioCryst charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 2.57 | |||
| Coefficient Of Variation | (1,067) | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.34 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 20.55 | |||
| Value At Risk | (6.47) | |||
| Potential Upside | 4.96 | |||
| Skewness | 0.0014 | |||
| Kurtosis | 1.37 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioCryst Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy BioCryst Stock please use our How to Invest in BioCryst Pharmaceuticals guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for BioCryst Stock analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is BioCryst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioCryst Pharmaceuticals. If investors know BioCryst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioCryst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Revenue Per Share 1.724 | Quarterly Revenue Growth 0.174 | Return On Assets (0.12) | Return On Equity (19.25) |
The market value of BioCryst Pharmaceuticals is measured differently than its book value, which is the value of BioCryst that is recorded on the company's balance sheet. Investors also form their own opinion of BioCryst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is BioCryst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioCryst Pharmaceuticals' market value can be influenced by many factors that don't directly affect BioCryst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioCryst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioCryst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioCryst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.